2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
Heating Up: CLS Holdings USA, Inc. Announces June Results, Increased Margins and Endorsement Deal
LAS VEGAS, NV / ACCESSWIRE / July 13, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'',...
Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with Aviptadil in the I-SPY COVID Trial
GENEVA, SWITZERLAND / ACCESSWIRE / July 13, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF, OTCQB:RLFTF) (" Relief "), a biopharmaceutical...
Rapid Nutrition Debuts ecommerce Site to Support Growing Global Demand for Health and Wellness Products Online
LONDON, UK / ACCESSWIRE / July 12, 2021 / Following on the heels of its successful Amazon store, Rapid Nutrition...
StageZero Life Sciences Announces New Ticker Symbol for OTC Markets
TORONTO, ON / ACCESSWIRE / July 12, 2021/ StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") is pleased to...
TRxADE HEALTH to Report Second Quarter 2021 Financial Results on Monday, July 26th at 4:30 p.m. Eastern Time
TAMPA, FL / ACCESSWIRE / July 12, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS) a health services IT company focused on...
WellSky® Leads Movement for Connected, Intelligent Care Through Launch of Value-Based Care Suite That Powers Lower Costs, Better Outcomes
Global technology and analytics company delivers innovative solutions to help providers, health systems, and payers successfully collaborate and succeed in...
Nationwide Survey Forecasts Big Tech Investment Ahead for Nursing Education
Findings point to a hybrid classroom geared for digital learners with emerging and existing technologies WALTHAM, Mass.--(BUSINESS WIRE)--#digitaleducation--New technology is...
Bleep, LLC Signs Distribution Agreement with Mercury Medical Expanding its Acute Care Commercial Capability in the U.S.
Mercury Medical announces Bleep, LLC partnership.CLEARWATER, FL / ACCESSWIRE / July 12, 2021 / Pressure ulcers not only drive high...
NervGen Pharma Expands Alzheimer’s Disease Scientific Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - July 12, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
Butterfly Appoints Two New Leaders to Drive Innovation and Health Technology Solutions
Dr. Andrei Stoica and David Ramsey will lead the effort to strengthen innovation and technology infrastructure as Chief Technology Officer...
Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$VCYT--Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers...
Establishment Labs Announces Departure of CFO and Appointment of Raj Denhoy as Interim CFO
Company also announces preliminary second quarter 2021 revenue of $31 million to $32 million SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings...
Owen Mumford Achieves B Corp Certification
UK medical device leader obtains certified commitment to social and environmental performance, accountability and transparency WOODSTOCK - OXFORDSHIRE, England, 12th...
Pharnext Announces First Patient Enrolled in Europe in the PREMIER Trial, its Pivotal Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)
PARIS, FRANCE / ACCESSWIRE / July 12, 2021 / Pharnext SA (FR0011191287 - ALPHA) (the 'Company'), an advanced late-stage clinical...
BioCryst Reports 96-week Data from APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate by 80 Percent from Baseline
—Multiple data presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2021 highlight durability of effect...
New, large, ‘real-world evidence’ study by ALK of AIT’s long-term effects on allergy and asthma presented at EAACI Congress
Leading allergy researchers present data from a new, large, ‘real-world evidence’ study of allergy immunotherapy at EAACI Annual Congress in...
Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress...
Pharvaris Presents Clinical Data on Oral PHA121 Supporting the Prophylactic Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021
Multiple doses of PHA121 were well-tolerated and showed a favorable pharmacokinetic profile for prophylactic treatment of HAEZUG, Switzerland, July 10,...
Celldex Therapeutics Presents Positive Data from CDX-0159 Phase 1b Study in Chronic Inducible Urticaria at EAACI 2021
- 95% complete response rate after single dose of CDX-0159 -- Rapid, profound and durable responses offer patients opportunity for...
Global $56.7 Billion Blockchain Market to 2026: Network Privacy, Security Concerns and Unsettled Regulatory Environment are Hindering the Market Growth
DUBLIN, July 9, 2021 /PRNewswire/ -- The "Global Blockchain Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global...